Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rxsight Inc (RXST)

Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 519,308
  • Shares Outstanding, K 41,117
  • Annual Sales, $ 139,930 K
  • Annual Income, $ -27,460 K
  • EBIT $ -45 M
  • EBITDA $ -51 M
  • 60-Month Beta 1.14
  • Price/Sales 3.67
  • Price/Cash Flow N/A
  • Price/Book 1.86

Options Overview Details

View History
  • Implied Volatility 208.87% (+19.78%)
  • Historical Volatility 66.58%
  • IV Percentile 87%
  • IV Rank 44.62%
  • IV High 408.96% on 10/29/25
  • IV Low 47.68% on 03/17/25
  • Expected Move (DTE 13) 2.82 (22.34%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 535
  • Volume Avg (30-Day) 142
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 5,141
  • Open Int (30-Day) 5,028
  • Expected Range 9.81 to 15.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.32
  • Low Estimate -0.62
  • Prior Year -0.15
  • Growth Rate Est. (year over year) -186.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.24 +53.28%
on 11/07/25
13.16 -4.03%
on 12/05/25
+4.29 (+51.44%)
since 11/05/25
3-Month
7.40 +70.68%
on 10/14/25
13.16 -4.03%
on 12/05/25
+3.74 (+42.07%)
since 09/05/25
52-Week
6.32 +99.84%
on 07/09/25
44.22 -71.44%
on 12/09/24
-29.65 (-70.13%)
since 12/05/24

Most Recent Stories

More News
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025  – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision...

RXST : 12.63 (+1.12%)
RxSight, Inc. Reports Third Quarter 2025 Financial Results

ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 12.63 (+1.12%)
RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

ALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) –  RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 12.63 (+1.12%)
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 12.63 (+1.12%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST

NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST). Such investors...

RXST : 12.63 (+1.12%)
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly...

RXST : 12.63 (+1.12%)
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

LOS ANGELES , Sept. 22, 2025 /PRNewswire/ --  The DJS Law Group  announces that it is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or "the Company") (NASDAQ:...

RXST : 12.63 (+1.12%)
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight,...

RXST : 12.63 (+1.12%)
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

NEW YORK , Sept. 20, 2025 /PRNewswire/ --

RXST : 12.63 (+1.12%)
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz reminds investors of the upcoming September 22, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed...

RXST : 12.63 (+1.12%)

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 13.73
2nd Resistance Point 13.44
1st Resistance Point 13.04
Last Price 12.63
1st Support Level 12.35
2nd Support Level 12.06
3rd Support Level 11.66

See More

52-Week High 44.22
Fibonacci 61.8% 29.74
Fibonacci 50% 25.27
Fibonacci 38.2% 20.80
Last Price 12.63
52-Week Low 6.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar